The evolving role of aromatase inhibitors in the treatment of early-stage breast cancer

被引：0
|
作者：
Paula D Ryan
Paul E Goss
机构：
[1] Director of the Breast and Ovarian Cancer Genetics Clinic at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School,
[2] Director of Breast Cancer Research at Massachusetts General Hospital,undefined
[3] and Professor of Medicine at Harvard Medical School,undefined
来源：
Nature Clinical Practice Oncology | 2005年 / 2卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Substantial progress has been made using aromatase inhibitors in early-stage breast cancer. This article highlights results from recent and ongoing trials of aromatase inhibitors as adjuvant therapy and discusses options for integration of these agents with tamoxifen in various subsets of patients and clinical scenarios.
引用
下载
收藏
页码：596 / 597
页数：1
相关论文
共 50 条
  • [21] Early discontinuation of tamoxifen and aromatase inhibitors (AIs) by postmenopausal women with early-stage breast cancer.
    Charlson, J. A.
    Hedin, T.
    Sparapani, R.
    Guo, C.
    Nattinger, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early stage breast cancer
    Ligibel, Jennifer A.
    Winer, Eric P.
    WOMENS HEALTH, 2006, 2 (01) : 89 - 97
  • [23] The evolving role of adjuvant radiotherapy for elderly women with early-stage breast cancer
    Rutter, Charles E.
    Lester-Coll, Nataniel H.
    Mancini, Brandon R.
    Corso, Christopher D.
    Park, Henry S.
    Yeboa, Debra N.
    Gross, Cary P.
    Evans, Suzanne B.
    CANCER, 2015, 121 (14) : 2331 - 2340
  • [24] Role of aromatase inhibitors in the treatment of breast cancer
    Choueiri, TK
    Alemany, CA
    Abou-Jawde, RA
    Budd, GT
    CLINICAL THERAPEUTICS, 2004, 26 (08) : 1199 - 1214
  • [25] Vitamin D deficiency in Australian early-stage breast cancer patients starting aromatase inhibitors
    Harris, M.
    Vincent, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] How We Maintain Bone Health in Early-Stage Breast Cancer Patients on Aromatase Inhibitors
    Bao, Ting k
    Davidson, Nancy E.
    JOURNAL OF ONCOLOGY PRACTICE, 2007, 3 (06) : 323 - 325
  • [27] Bone Density Screening in Postmenopausal Women With Early-Stage Breast Cancer Treated With Aromatase Inhibitors
    Stratton, Jamie
    Hu, Xin
    Soulos, Pamela R.
    Davidoff, Amy J.
    Pusztai, Lajos
    Gross, Cary P.
    Mougalian, Sarah S.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : E505 - E515
  • [28] Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: A review of the evidence
    Litsas, Georgia
    ONCOLOGY NURSING FORUM, 2008, 35 (04) : 714 - 721
  • [29] Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer
    Crew, Katherine D.
    Greenlee, Heather
    Capodice, Jillian
    Raptis, George
    Brafman, Lois
    Fuentes, Deborah
    Sierra, Alex
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3877 - 3883
  • [30] Could treatment with tamoxifen be superior to aromatase inhibitors in early-stage breast cancer after pharmacogenomic testing? A modeling analysis
    Punglia, R. S.
    Winer, E. P.
    Weeks, J. C.
    Burstein, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345